Caibin Sheng is a data scientist at Oncology Data Science, Novartis Institute for BioMedical Research. He received his Ph.D. degree in systems biology in 2017 from Humboldt-Universität Zu Berlin, Germany, and developed an interest in AI drug development afterward. In Novartis, he dedicates himself to searching for potential anti-tumor drug targets using AI and genomics data.